The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ISHL12 | The importance of cardio-oncology in the treatment of patients with hematological malignancies
In this video, Jenica Upshaw, MD, Tufts University, Boston, MA, briefly discusses the role of cardio-oncology in the treatment of patients with hematological malignancies including Hodgkin lymphoma (HL), and explains the importance of optimizing cardiovascular health to improve patient outcomes. This interview took place at The 12th International Symposium on Hodgkin Lymphoma (ISHL12), held in Cologne, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
